Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01828593 · ClinicalTrials.gov registry record · NA
Impact of SBI, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy
A NA study, sponsored by Entera Health.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT01828593 is a NA study that has completed, run by Entera Health. The registered enrollment target is 103 participants.
The verdict
NCT01828593, a NA study, has completed, sponsored by Entera Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the effectiveness of the oral nutritional therapy serum-derived bovine immunoglobulin protein isolate (SBI) 2.5 g twice a day (BID) and SBI 5.0 g versus placebo on supporting nutrient absorption in HIV+ subjects with HIV-associated enteropathy.
Interventions
- OTHER Placebo
- OTHER Serum-derived bovine immunoglobulin protein isolate (SBI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01828593
The ClinicalTrials.gov registry entry for NCT01828593 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Entera Health, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01828593 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01828593 about?
NCT01828593 is a clinical study titled "Impact of SBI, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy". The purpose of the study is to evaluate the effectiveness of the oral nutritional therapy serum-derived bovine immunoglobulin protein isolate (SBI) 2.5 g twice a day (BID) and SBI 5.0 g versus placebo on supporting nutrient absorption in HIV+ subjects with HIV-associated enteropathy.
What is the current status of trial NCT01828593?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2013-04. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01828593?
The interventions under investigation include: Placebo (OTHER), Serum-derived bovine immunoglobulin protein isolate (SBI) (OTHER).
Who is sponsoring clinical trial NCT01828593?
This trial is sponsored by Entera Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.